Vivo Capital, LLC Codexis, Inc. Transaction History

Vivo Capital, LLC

$683 Million
Q3 2024

A detailed history of Vivo Capital, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 388,144 shares of CDXS stock, worth $1.68 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

388,144

Previous 388,144 -0.0%

Holding current value

$1.68 Million

Previous $1.2 Million 0.67%

% of portfolio

0.17%

Previous 0.18%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$11.7 - $23.41 $12.7 Million - $25.5 Million	-1,088,145 Reduced 73.71%	388,144 $8.47 Million
Q3 2020 Nov 13, 2020	SELL	$11.21 - $13.82 $197,452 - $243,425	-17,614 Reduced 1.18%	1,476,289 $17.3 Million
Q1 2020 May 15, 2020	BUY	$8.78 - $18.6 $13.1 Million - $27.8 Million	1,493,903 New	1,493,903 $16.7 Million
Q3 2019 Nov 13, 2019	SELL	$12.75 - $19.01 $33.3 Million - $49.7 Million	-2,614,458 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$17.0 - $21.88 $76,381 - $98,306	-4,493 Reduced 0.17%	2,614,458 $48.2 Million
Q1 2019 May 14, 2019	SELL	$15.53 - $22.15 $1.48 Million - $2.12 Million	-95,507 Reduced 3.52%	2,618,951 $53.8 Million
Q4 2018 Feb 13, 2019	SELL	$14.06 - $22.57 $490,483 - $787,354	-34,885 Reduced 1.27%	2,714,458 $45.3 Million
Q3 2018 Nov 13, 2018	SELL	$13.35 - $19.1 $4.08 Million - $5.83 Million	-305,482 Reduced 10.0%	2,749,343 $47.2 Million
Q3 2017 Nov 13, 2017	BUY	$4.9 - $6.65 $15 Million - $20.3 Million	3,054,825	3,054,825 $20.3 Million

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $284M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Account